BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 207786)

  • 1. Salivary neutralizing activity against herpes simplex virus type 1.
    Gyselink R; Coles D; Ash RJ; Fritz ME
    J Infect Dis; 1978 May; 137(5):583-6. PubMed ID: 207786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus microneutralization: a simplification of the test.
    Stalder H; Oxman MN; Herrmann KL
    J Infect Dis; 1975 Apr; 131(4):423-30. PubMed ID: 163870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing serum IgM antibodies in infections with Herpes simplex virus hominis.
    Doerr HW; Gross G; Schmitz H
    Med Microbiol Immunol; 1976 Dec; 162(3-4):183-92. PubMed ID: 187917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of herpes simplex virus type 1 (HSV-1) plaque enlargement by neutralizing sera.
    Mannini-Palenzona A; Costanzo F; Foà-Tomasi L; Negosanti M; Lanzoni A
    Microbiologica; 1989 Jul; 12(3):231-40. PubMed ID: 2476650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of herpes simplex virus in children by detection of specific antibodies in saliva.
    Spicher VM; Bouvier P; Schlegel-Haueter SE; Morabia A; Siegrist CA
    Pediatr Infect Dis J; 2001 Mar; 20(3):265-72. PubMed ID: 11303828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary defense factors in herpes simplex virus infection.
    Välimaa H; Waris M; Hukkanen V; Blankenvoorde MF; Nieuw Amerongen AV; Tenovuo J
    J Dent Res; 2002 Jun; 81(6):416-21. PubMed ID: 12097435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
    Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
    Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus.
    Coughlan BM; Skinner GR
    Br J Obstet Gynaecol; 1977 Aug; 84(8):622-9. PubMed ID: 196613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence and neutralizing antibodies to herpes simplex virus in the cerebrospinal fluid of patients with central nervous system diseases.
    Leventon-Kriss S; Rannon L; Joffe R
    Isr J Med Sci; 1976 Jun; 12(6):553-9. PubMed ID: 182656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of protein A-treated sera in unmasking herpes simplex virus type 1 (HSV-1) immunoglobulin A and identifying HSV-1 immunoglobulin G as the predominant neutralizing antibody.
    Ratner JJ; Sanford BA; Smith KO
    J Clin Microbiol; 1979 Oct; 10(4):415-8. PubMed ID: 231047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A seroepidemiological survey of herpes simplex virus in pregnant women by microneutralization test and ELISA (author's transl)].
    Hayashi Y; Mori R; Minamishima Y; Hamada T; Tateyama H; Sugawara H; Yamamoto S
    Kansenshogaku Zasshi; 1982 Feb; 56(2):118-25. PubMed ID: 6286805
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutralizing antibody to herpes simplex virus by a novel neutralization method with peroxidase-labelled complement Clq.
    Taguchi F; Kawasaki T; Matsuzaki T; Lee SM
    J Virol Methods; 1991 May; 32(2-3):157-62. PubMed ID: 1651947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
    Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory IgA against herpes simplex virus in cervical secretions.
    Persson E; Eneroth P; Jeansson S
    Genitourin Med; 1988 Dec; 64(6):373-7. PubMed ID: 2852157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies of the IgG and IgM classes to herpes simplex virus type 1 in cerebrospinal fluid and serum from four patients with herpes encephalitis.
    Rapicetta M; Morace G; Alema G; Mancini G
    Microbiologica; 1984 Jul; 7(3):273-7. PubMed ID: 6094987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme immunoassay for measurement of antibodies to herpes simplex virus infection: comparison with complement fixation, immunofluorescent-antibody, and neutralization techniques.
    Denoyel GA; Gaspar A; Nouyrigat C
    J Clin Microbiol; 1980 Feb; 11(2):114-9. PubMed ID: 6244329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies against herpes simplex virus in maternal and umbilical cord serum.
    Ishiguro T; Ozaki Y
    Acta Obstet Gynecol Scand; 1979; 58(4):413-4. PubMed ID: 230696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
    Jankowski MA; Petersen EE; Böcker JF
    Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serologic examination for childhood herpes simplex virus infection].
    Tang JP; Yang YJ; Zhang D; Li LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):476-8. PubMed ID: 17178039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.